NRIX - Nurix Therapeutics, Inc.
9.5
-0.140 -1.474%
Share volume: 575,746
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$9.64
-0.14
-0.01%
Summary score
35%
Profitability
18%
Dept financing
8%
Liquidity
75%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.29%
Return on assets
-10.1%
Return on sales
-377.52%
Return on invested capital
-5.28%
Total debt ratio
28.31%
Debt ratio change over timeo
-1.26%
Current Ratio
5.07%
Quick Ratio
5.02%
Cash Position Ratio
3.62%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.02%
Return on assets
-9.79%
Return on sales
-409.61%
Return on invested capital
223.12%
Total debt ratio
23.51%
Debt ratio change over timeo
-0.83%
Current Ratio
6.1%
Quick Ratio
5.57%
Cash Position Ratio
2.49%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.22%
Return on sales
-340.67%
Return on invested capital
0%
Total debt ratio
21.81%
Debt ratio change over time
0%
Current Ratio
6.26%
Quick Ratio
0%
Cash Position Ratio
0.84%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-85.5%
Return on assets
-92.49%
Return on sales
312.05%
Return on invested capital
35.3%
Total debt ratio
-125.84%
Debt ratio change over time
-1.26%
Current Ratio
-6.36%
Quick Ratio
-8.22%
Cash Position Ratio
-6.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NRIX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -13.29% | 14.28% | 9.23% | 0% |
| Return on assets | -10.1% | 4.23% | 3.2% | 0% |
| Return on sales | -377.52% | 27.89% | 25.03% | 0% |
| Return on invested capital | -5.28% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 28.31% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | -1.26% | -11.36% | -57.43% | 0% |
| Dept financing | 9% | 25% | 18% | 25% |
| Current Ratio | 6.1% | 1.23% | 1.12% | 0% |
| Quick Ratio | 5.57% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.49% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 12% | 15% | 0% |
| Short-term ratios | NRIX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -12.02% | 0% | 0% | 0% |
| Return on assets | -9.79% | 4.32% | 3.49% | 0% |
| Return on sales | -409.61% | 28.32% | 23.63% | 0% |
| Return on invested capital | 223.12% | 0% | 0% | 0% |
| Profitability | 25% | 50% | 66% | 0% |
| Total debt ratio | 23.51% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | -0.83% | 0% | 0% | 0% |
| Dept financing | 7% | 25% | 43% | 0% |
| Current Ratio | 6.1% | 1.23% | 1.12% | 0% |
| Quick Ratio | 5.57% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.49% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 11% | 14% | 0% |
